The A.I.M.M. Trial: a Phase 3 clinical study of Allovectin-7® Immunotherapeutic
A Clinical Trial for Individuals with
Stage 3 or Stage 4 Melanoma
If you have been diagnosed with Stage 3 or Stage 4
melanoma, you may be able to participate in a
clinical trial evaluating Allovectin-7®,
an investigational product.
Interested in participating?
Click the button below to answer a short series of questions to help determine whether you pre-qualify to participate.
Your participation could make a difference. What researchers learn from this study may contribute to the advancement of late stage melanoma treatments.
What is The A.I.M.M. Trial?
The purpose of the A.I.M.M. Trial is to find out whether Allovectin-7® works better than standard chemotherapy for people with Stage 3 or Stage 4 melanoma.
Allovectin-7® is an investigational product for certain types of cancer. This product is designed to work with your body's immune system to recognize and destroy tumor cells. This type of therapy is called immunotherapy.
This site is powered by The Patient Recruiting Agency.